Pharmatech

Caris Life Sciences Raises $310M to Continue Rapidly Growing in the Precision Medicine Market

by | Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE
Caris Life Sciences Acquires Pharmatech to Pair Patients with Clinical Trials, Faster
by | May 2, 2019
Using a patient's molecular makeup, Caris and Pharmatech aim to find the perfect clinical trial for each cancer patient—and enroll them in as little as 10 days.
MORE